These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22287401)

  • 21. Continuous Infusion versus Intermittent Dosing with Pantoprazole for Gastric Endoscopic Submucosal Dissection.
    Lee BE; Kim GH; Song GA; Seo JH; Jeon HK; Baek DH; Kim DU
    Gut Liver; 2019 Jan; 13(1):40-47. PubMed ID: 30400726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers.
    Chen CC; Lee JY; Fang YJ; Hsu SJ; Han ML; Tseng PH; Liou JM; Hu FC; Lin TL; Wu MS; Wang HP; Lin JT
    Aliment Pharmacol Ther; 2012 Apr; 35(8):894-903. PubMed ID: 22369682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bravo capsule system optimizes intragastric pH monitoring over prolonged time: effects of ghrelin on gastric acid and hormone secretion in the rat.
    Rudholm T; Hellstrom PM; Theodorsson E; Campbell CA; McLean PG; Naslund E
    World J Gastroenterol; 2008 Oct; 14(40):6180-7. PubMed ID: 18985808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.
    Devault KR
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):197-205. PubMed ID: 19072410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral rabeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects.
    Armstrong D; James C; Camacho F; Chen Y; Horbay GL; Teixeira B; Husein-Bhabha FA
    Aliment Pharmacol Ther; 2007 Jan; 25(2):185-96. PubMed ID: 17116123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome.
    Ramdani A; Mignon M; Samoyeau R
    Gastroenterol Clin Biol; 2002 Apr; 26(4):355-9. PubMed ID: 12070410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics, Pharmacodynamics and Safety of Multiple-Infusion Ilaprazole in Healthy Chinese Subjects.
    Wang H; Lang L; Ou N; Shi R; Hu H; Hu P; Jiang J
    Clin Drug Investig; 2016 Jun; 36(6):463-70. PubMed ID: 27067231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison on Oral versus Intravenous Proton Pump Inhibitors for Prevention of Bleeding after Endoscopic Submucosal Dissection of Gastric Lesions].
    Jung YS; Kim KO; Lee SH; Jang BI; Kim TN
    Korean J Gastroenterol; 2016 Feb; 67(2):74-80. PubMed ID: 26907482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH.
    Kirchheiner J; Glatt S; Fuhr U; Klotz U; Meineke I; Seufferlein T; Brockmöller J
    Eur J Clin Pharmacol; 2009 Jan; 65(1):19-31. PubMed ID: 18925391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.
    Kim YS; Kim SJ; Yoon JH; Suk KT; Kim JB; Kim DJ; Kim DY; Min HJ; Park SH; Shin WG; Kim KH; Kim HY; Baik GH
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1098-105. PubMed ID: 21923713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose pantoprazole continuous infusion is superior to somatostatin after endoscopic hemostasis in patients with peptic ulcer bleeding.
    Tsibouris P; Zintzaras E; Lappas C; Moussia M; Tsianos G; Galeas T; Potamianos S
    Am J Gastroenterol; 2007 Jun; 102(6):1192-9. PubMed ID: 17378909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors.
    Schneider JL; Kolitsopoulos F; Corley DA
    Aliment Pharmacol Ther; 2016 Jan; 43(1):73-82. PubMed ID: 26541643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily--a randomized, two-way crossover study.
    Miehlke S; Madisch A; Kirsch C; Lindner F; Kuhlisch E; Laass M; Knoth H; Morgner A; Labenz J
    Aliment Pharmacol Ther; 2005 Apr; 21(8):963-7. PubMed ID: 15813831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized trial comparing pantoprazole infusion, bolus and no treatment on gastric pH and recurrent bleeding in peptic ulcers.
    Hung WK; Li VK; Chung CK; Ying MW; Loo CK; Liu CK; Lam BY; Chan MC
    ANZ J Surg; 2007 Aug; 77(8):677-81. PubMed ID: 17635283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults.
    Pratha VS; Hogan DL; Lane JR; Williams PJ; Burton MS; Lynn RB; Karlstadt RG
    Dig Dis Sci; 2006 Jan; 51(1):123-31. PubMed ID: 16416224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effects of esomeprazole 40 mg, rabeprazole 20 mg, lansoprazole 30 mg, and pantoprazole 40 mg on intragastrıc pH in extensive metabolizer patients with gastroesophageal reflux disease.
    Çelebi A; Aydın D; Kocaman O; Konduk BT; Şentürk Ö; Hülagü S
    Turk J Gastroenterol; 2016 Sep; 27(5):408-414. PubMed ID: 27782887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intragastric pH with oral versus intravenous bolus plus infusion proton pump inhibitor therapy in patients with bleeding ulcers.
    Lin HJ; Tsai JJ
    Gastroenterology; 2008 Nov; 135(5):1804-5. PubMed ID: 18840442
    [No Abstract]   [Full Text] [Related]  

  • 38. [Intravenous proton-pump inhibitor for acute peptic ulcer bleeding--is profound acid suppression beneficial to reduce the risk of rebleeding?].
    Garrido A; Giráldez A; Trigo C; Leo E; Guil A; Márquez JL
    Rev Esp Enferm Dig; 2008 Aug; 100(8):466-9. PubMed ID: 18942898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer.
    van Rensburg CJ; Hartmann M; Thorpe A; Venter L; Theron I; Lühmann R; Wurst W
    Am J Gastroenterol; 2003 Dec; 98(12):2635-41. PubMed ID: 14687809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-response evaluation of the antisecretory effect of continuous infusion intravenous lansoprazole regimens over 48 h.
    Howden CW; Metz DC; Hunt B; Vakily M; Kukulka M; Amer F; Samra N
    Aliment Pharmacol Ther; 2006 Apr; 23(7):975-84. PubMed ID: 16573800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.